参考文献/References:
[1] PRASANNA T, CRAFT P, BALASINGAM G, et al.Intravesical gemcitabine versusIntravesical bacillusCalmette-Guerin for the treatment of Non-MuscleInvasiveBladder cancer:an evaluation of efficacy andtoxicity[J]. Frontiers in Oncology, 2017, 7(31): 2601-2611.
[2] 胡卫锋，郭永连，陈琳，等．非肌层浸润性膀胱癌术后吉西他滨与表柔比星膀胱灌注化疗疗效及安全性分析[J]．现代泌尿生殖肿瘤杂志，2017，9（5）：269-271． HU Weifeng, GUO Yonglian, CHEN Lin, et al.Comparison of the efficacy and safety betweengemcitabine and epirubicin in intravesical instillationchemotherapy for non-muscle-invasive bladdercancer [J]. Journal of Contemporary Urologic andReproductive Oncology, 2017,9 (5): 269-271.
[3] 张西玲，刘春来．TRPV4 活化调控炎性小体Nod样受体家族3 在小鼠膀胱上皮细胞损伤中作用和机制研究[J]．中华实用诊断与治疗杂志，2019，33（6）：524-527． ZHANG Xiling, LIU Chunlai. Role of TRPV4 inbladder epithelial cell injury in mouse by activatingNLRP3 inflammasome and its mechanism. [J]. Journalof Chinese Practical Diagnosis and Therapy , 2019,33(6): 524-527.
[4] 姜丰泽，蒋思雄，田丰，等．鸦胆子油乳联合常规化疗方案对局部晚期膀胱癌患者的疗效观察及免疫功能的影响[J]．中华保健医学杂志，2019，21（1）：24-27． JIANG Fengze, JIANG Sixiong, TIAN Feng, et al.Effect of brucea javanica oil emulsion combined withroutine chemotherapy on patients with locally advancedbladder cancer and immune function [J]. Chin J HealthCare Med, 2019,21 (1): 24-27.
[5] 熊巧，曾蜀雄，阳青松，等．多参数磁共振在膀胱癌病理分级和T 分期中的研究新进展[J]．临床泌尿外科杂志，2020, 35（1）: 68-73.XIONG Qiao, ZENG Shuxiong, YANG Qingsong,et al. Advances in multiparametric MRI in gradingand staging of bladder cancer [J]. Journal of ClinicalUrology, 2020, 35（1）: 68-73．
[6] 方虹, 连俊红. 外周血炎症指标在子宫颈癌变进程中的动态变化及临床意义[J]．解放军医药杂志，2019, 31（11）: 32-36． FANG Hong, LIAN Junhong. Dynamic changesof inflammatory biomarkers in peripheral blood inprogression of cervical carcinogenesis and their clinicalsignificances[J]. Medical & Pharmaceutical Journal ofChinese People’s Liberation Army, 2019,31 (11): 32-36.
[7] KOSE N, YILDIRIM T, AKIN F, et al. Prognostic roleof NLR, PLR, and LMR in patients with pulmonaryembolism[J]. Bosnian Journal of Basic MedicalSciences, 2019, 40(33): 1124-1136.
[8] YAMADA Y, TAKAYAMA K I, FUJIMURA T, etal. A novel prognostic factor TRIM44 promotes cellproliferation and migration,and inhibits apoptosis intesticulargerm cell tumor[J]. Cancer Science, 2017,108(1): 32-41.
[9] 吴辰．乌司他丁辅助治疗宫颈癌患者急性放射性肠炎的疗效及对炎性因子的影响[J]．临床合理用药杂志，2019, 12（31）: 77-78． WU Chen .Effect of ulinastatin on acute radiationenteritis in patients with cervical cancer and itsinfluence on inflammatory factors [J]. Chinese Journalof Clinical Rational Drug Use, 2019,12 (31): 77-78.
[10] 施骅，潘俊娣，叶斌．替吉奥联合卡培他滨对胆囊癌患者炎性因子和淋巴细胞功能的影响[J]．中华全科医学, 2017, 15（6）: 954-956． SHI Hua, PAN Jundi, YE Bin. The influence of tegafurcombined with capecitabine on inflammatory factorsand lymphocyte function of patients with gallbladdercancer [J]. Chinese Journal of General Practice,2017,15 (6): 954-956.
[11] BENANMIN W, FISCHER V, BRIAN C, et al.Baumann reply to:dose-escalation of radiation Mayimprove outcomes of squamous cell carcinoma ofbladder[J]. Clinical and Translational RadiationOncology, 2019, 20(14): 874-881.
[12] 薛森耀，王晓，钟修龙，等．原发性膀胱小细胞癌的诊断和治疗[J]．中华腔镜泌尿外科杂志( 电子版)，2016, 10（5）: 17-20． XUE Senyao, WANG Xiao, ZHONG Xiulong, et al.Primary small cell carcinoma of the bladder: 7 casesreport and literature review[J]. Chinese Journal ofEndourology(Electronic Version), 2016,10 (5): 17-20.
[13] 李海燕，郑锦羽，王娟，等．欣力康胶囊对膀胱癌5637 细胞增殖抑制与转移潜能作用机制研究[J]．中华肿瘤防治杂志，2019, 26（8）: 529-534． LI Haiyan, ZHENG Jinyu, WANG Juan, et al.Mechanism of Xinlikang capsule inhibitingproliferation and metastasis of 5 637 bladder cancercells [J]. Chinese Journal of Cancer Prevention andTreatment, 2019, 26 (8): 529-534.
[14] 高翔，刘志宇，王梁，等．术前中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值对非肌层浸润性膀胱癌的预后评估价值[J]. 中国医科大学学报，2019, 48（7）: 638-642． GAO Xiang, LIU Zhiyu, WANG Liang, et al.Prognostic evaluation values of preoperative neutrophillymphocyteand platelet-lymphocyte ratios in nonmuscularinvasive bladder cancer [J]. Journal of ChinaMedical University, 2019, 48 (7): 638-642.
[15] TAKASHIMA Y, MURAKAMI T, INOUE T, et al.Manifestation of osteoblasticphenotypes in the sarcomatouscomponent of epithelial carcinoma andsarcomatoidcarcinoma[J]. Tumour Biology : 2017, 39(6):1393-1399.
[16] 汪赛，梁朝朝，周骏，等．中性- 淋巴细胞比和预后营养指数在膀胱癌根治术患者预后评估中的价值[J]．安徽医科大学学报，2019, 54（4）: 640-646． WANG Sai, LIANG Chaochao, ZHOU Jun, et al. Thevalue of neutrophil-lymphocyte ratio and prognosticnutritional index in the prognosis of patients withbladder cancer after radical cystectomy [J]. ActaUniversitatis Medicinalis Anhui, 2019,54 (4): 640-646.
[17] 孙磊，王会平，熊术道，等．多发性骨髓瘤患者中性粒细胞与淋巴细胞比值与预后的关系[J]．安徽医科大学学报，2016, 51（5）: 721-724． SUN Lei, WANG Huiping, XIONG Shudao, et al.Neutrophils and lymphocytes ratio on the prognosis ofpatients with multiple myeloma [J]. Acta UniversitatisMedicinalis Anhui, 2016,51 (5): 721-724.
[18] 王大明，于德新，谢栋栋，等．预后营养指数和中性粒细胞/ 淋巴细胞比值在根治性膀胱切除加尿流改道术后早期并发症风险评估中的应用研究[J]．安徽医科大学学报, 2019, 54（7）: 1132-1136． WANG Daming, YU Dexin, XIE Dongdong, et al.The application of onodera prognostic nutrition index(OPNI) and neutrophils to lymphocyte ratio (NLＲ ) in risk assessment of early complications afterradical cystectomy plus urinary diversion [J]. ActaUniversitatis Medicinalis Anhui, 2019,54 (7): 1132-1136.
[19] 王云华，黄灵坚．血小板与淋巴细胞比值在上皮性卵巢癌病情监测中的价值[J]．检验医学与临床，2015, 12（23）: 3517-3518, 3521． WANG Yunhua, HUANG Lingjian. Significanceof PLR for the monitor of epithelial ovariancancer[J]. Laboratory Medicine and Clinic, 2015, 12（23）: 3517-3518, 3521．
[20] 郭进京，胡林辉，陶千山，等．红细胞分布宽度在多发性骨髓瘤患者预后分期中的价值[J]．现代检验医学杂志, 2017,32（3）: 34-36, 39． GUO Jinjing, HU Linhui, TAO Qianshan, et al.Value of red cell distribution width in the prognosis ofpatients with multiple myeloma[J]. Journal of ModernLaboratory Medicine, 2017, 32（3）: 34-36, 39．